JP2014520117A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014520117A5 JP2014520117A5 JP2014515342A JP2014515342A JP2014520117A5 JP 2014520117 A5 JP2014520117 A5 JP 2014520117A5 JP 2014515342 A JP2014515342 A JP 2014515342A JP 2014515342 A JP2014515342 A JP 2014515342A JP 2014520117 A5 JP2014520117 A5 JP 2014520117A5
- Authority
- JP
- Japan
- Prior art keywords
- virus
- chikungunya virus
- vaccine composition
- composition according
- oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN2067/CHE/2011 | 2011-06-17 | ||
| IN2067CH2011 | 2011-06-17 | ||
| PCT/IN2012/000432 WO2012172574A1 (en) | 2011-06-17 | 2012-06-18 | Vaccine composition comprising an inactivated chikungunya virus strain |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014520117A JP2014520117A (ja) | 2014-08-21 |
| JP2014520117A5 true JP2014520117A5 (enExample) | 2015-07-16 |
| JP6147734B2 JP6147734B2 (ja) | 2017-06-14 |
Family
ID=46601866
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014515342A Expired - Fee Related JP6147734B2 (ja) | 2011-06-17 | 2012-06-18 | 不活化チクングニアウイルス株を含むワクチン組成物 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US9844588B2 (enExample) |
| EP (1) | EP2720715B1 (enExample) |
| JP (1) | JP6147734B2 (enExample) |
| KR (1) | KR101792684B1 (enExample) |
| CN (1) | CN103796676B (enExample) |
| AU (1) | AU2012269907B2 (enExample) |
| BR (1) | BR112013032251B1 (enExample) |
| MY (1) | MY173117A (enExample) |
| PH (1) | PH12013502621A1 (enExample) |
| SG (1) | SG10201607787RA (enExample) |
| WO (1) | WO2012172574A1 (enExample) |
| ZA (1) | ZA201309386B (enExample) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX357202B (es) * | 2012-02-16 | 2018-06-28 | Vlp Therapeutics Llc | Composicion de particula tipo virus. |
| TWI676636B (zh) | 2013-07-12 | 2019-11-11 | Ｖｌｐ醫療股份有限公司 | 包含ｐｄ－１抗原或ｐｄ－１配體抗原的類病毒粒子 |
| US10385101B2 (en) | 2014-08-08 | 2019-08-20 | Vlp Therapeutics, Llc | Virus like particle comprising modified envelope protein E3 |
| TWI720946B (zh) | 2014-08-08 | 2021-03-11 | 美商Ｖｌｐ醫療股份有限公司 | 包含改質套膜蛋白質ｅ３之類病毒粒子 |
| CA2960102C (en) | 2014-09-11 | 2023-10-24 | Vlp Therapeutics, Llc | Flavivirus virus like particle |
| CA2992531C (en) * | 2015-07-16 | 2023-09-26 | Bharat Biotech International Limited | Vaccine compositions |
| US20190054161A1 (en) * | 2016-01-13 | 2019-02-21 | United States, As Represented By The Secretary Of The Army | Inactivated vaccine for chikungunya virus |
| CN105906694B (zh) * | 2016-05-05 | 2019-05-14 | 中国人民解放军军事医学科学院微生物流行病研究所 | 基孔肯亚病毒特异性检测抗原及其应用 |
| PH12018502460B1 (en) * | 2016-05-27 | 2023-11-08 | Univ Griffith | Arthrogenic alphavirus vaccine |
| KR101875055B1 (ko) * | 2016-10-19 | 2018-07-06 | 연세대학교 원주산학협력단 | 융합 단백질 및 그의 용도 |
| KR102007203B1 (ko) * | 2016-10-20 | 2019-08-05 | 연세대학교 원주산학협력단 | 융합 단백질 및 그의 용도 |
| WO2018074884A1 (ko) * | 2016-10-20 | 2018-04-26 | 연세대학교 원주산학협력단 | 재조합 단백질 및 그의 용도 |
| CN118662621A (zh) * | 2017-09-21 | 2024-09-20 | 瓦尔尼瓦公司 | 包含免疫原性屈公病毒chikv-delta5nsp3的医药组成物的制备方法 |
| MY202505A (en) | 2017-11-03 | 2024-05-01 | Takeda Vaccines Inc | Zika vaccines and immunogenic compositions, and methods of using the same |
| SG11202003975WA (en) | 2017-11-30 | 2020-06-29 | Takeda Vaccines Inc | Method for inactivating zika virus and related methods |
| KR102823029B1 (ko) | 2017-12-20 | 2025-06-20 | 브이엘피 테라퓨틱스 인코포레이티드 | 알파바이러스 레플리콘 입자 |
| WO2019148086A1 (en) * | 2018-01-26 | 2019-08-01 | The Wistar Institute Of Anatomy And Biology | Vaccines against mosquito-borne viruses, and methods of using same |
| CN109536464B (zh) * | 2018-12-10 | 2022-06-10 | 中国科学院武汉病毒研究所 | 一种缺失衣壳蛋白基因的基孔肯雅病毒感染性克隆及构建方法和在制备减毒疫苗中的应用 |
| KR102016668B1 (ko) | 2018-12-19 | 2019-08-30 | 주식회사 엠디헬스케어 | 치쿤군야 바이러스 e2에 특이적으로 결합하는 dna 압타머 및 이의 용도 |
| US11562105B2 (en) * | 2019-07-11 | 2023-01-24 | Yokogawa Electric Corporation | System and method for module engineering with sequence libraries |
| KR102202082B1 (ko) | 2019-09-25 | 2021-01-11 | 충북대학교 산학협력단 | 치쿤군야 바이러스의 외피단백질 도메인 ⅱ에 대해 특이적으로 결합하는 단일클론항체, 이를 생산하는 하이브리도마 세포주 및 이의 용도 |
| TWI891771B (zh) | 2020-04-17 | 2025-08-01 | 美商Ｖｌｐ醫療股份有限公司 | 冠狀病毒疫苗 |
| MX2022013638A (es) | 2020-04-30 | 2023-01-24 | Vlp Therapeutics Inc | Inmunoterapia con citocina. |
| AU2021315795A1 (en) * | 2020-07-31 | 2023-02-23 | Replicate Bioscience, Inc. | Modified Chikungunya viruses and Sindbis viruses and uses thereof |
| CN117771353B (zh) * | 2024-02-27 | 2024-05-14 | 中国医学科学院医学生物学研究所 | 一种以包膜蛋白为靶标的基孔肯雅病毒的mRNA疫苗及其制备方法 |
| CN118561969B (zh) * | 2024-08-02 | 2024-11-19 | 中国医学科学院医学生物学研究所 | 一种通过优化全长结构蛋白序列设计的基孔肯雅病毒广谱性mRNA疫苗 |
| KR102864666B1 (ko) * | 2025-04-21 | 2025-09-29 | 대한민국 | 치쿤구니아 바이러스 외피 재조합 dna를 포함하는 백신 조성물 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100233209A1 (en) * | 2005-08-11 | 2010-09-16 | Higgs Stephen T | Chikungunya virus infectious clones and uses therefor |
| BRPI0716145B1 (pt) | 2006-09-01 | 2021-06-22 | Bharat Biotech International Limited | Composição de vacina e método para preparar uma composição de vacina para o vírus chikungunya |
| JP2009149583A (ja) * | 2007-12-21 | 2009-07-09 | National Institute Of Biomedical Innovation | フラビウイルス感染症ワクチンおよびフラビウイルス感染症ワクチン用アジュバント |
| CN102317308A (zh) | 2008-11-26 | 2012-01-11 | 美国国有健康与人类服务部 | 类病毒组合物颗粒及其使用方法 |
-
2012
- 2012-06-18 CN CN201280029793.9A patent/CN103796676B/zh active Active
- 2012-06-18 EP EP12741389.6A patent/EP2720715B1/en active Active
- 2012-06-18 PH PH1/2013/502621A patent/PH12013502621A1/en unknown
- 2012-06-18 KR KR1020147000963A patent/KR101792684B1/ko not_active Expired - Fee Related
- 2012-06-18 WO PCT/IN2012/000432 patent/WO2012172574A1/en not_active Ceased
- 2012-06-18 MY MYPI2013004491A patent/MY173117A/en unknown
- 2012-06-18 AU AU2012269907A patent/AU2012269907B2/en not_active Ceased
- 2012-06-18 BR BR112013032251-9A patent/BR112013032251B1/pt not_active IP Right Cessation
- 2012-06-18 US US14/126,504 patent/US9844588B2/en active Active
- 2012-06-18 JP JP2014515342A patent/JP6147734B2/ja not_active Expired - Fee Related
- 2012-06-18 SG SG10201607787RA patent/SG10201607787RA/en unknown
-
2013
- 2013-12-12 ZA ZA2013/09386A patent/ZA201309386B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10022434B2 (en) | Influenza nucleic acid molecules and vaccines made therefrom | |
| US20160038584A1 (en) | Influenza Nucleic Acid Molecules And Vaccines Made Therefrom | |
| US11123421B2 (en) | Cold adapted and virulence factor deleted live attenuated vaccine suitable for mucosal delivery | |
| JP2014520117A (ja) | 不活化チクングニアウイルス株を含むワクチン組成物 | |
| JP5675789B2 (ja) | 免疫接種のための発現ベクターとしての水疱性口内炎ウイルスの異なる複数の抗原型 | |
| CA2835967A1 (en) | Papaya mosaic virus compositions and uses thereof for stimulation of the innate immune response | |
| Operschall et al. | Enhanced protection against viral infection by co-administration of plasmid DNA coding for viral antigen and cytokines in mice | |
| JP2019520090A (ja) | 弱毒変異型ジカウイルスを含むワクチン組成物 | |
| JP7849046B2 (ja) | インフルエンザウイルスバックボーン | |
| Hoover et al. | N-dihydrogalactochitosan serves as an effective mucosal adjuvant for intranasal vaccine in combination with recombinant viral proteins against respiratory infection | |
| JP7046848B2 (ja) | 弱毒化突然変異体ジカウイルスをコードするゲノム配列 | |
| Jimenez et al. | COVID-19 vaccine race: analysis of age-dependent immune responses against SARS-CoV-2 indicates that more than just one strategy may be needed | |
| Sarkar et al. | Formulation of the respiratory syncytial virus fusion protein with a polymer-based combination adjuvant promotes transient and local innate immune responses and leads to improved adaptive immunity | |
| KR102723171B1 (ko) | 신규한 코로나 바이러스의 에피토프 및 이의 용도 | |
| EP3708187A1 (en) | Single high dose of mva induces a protective immune response in neonates and infants | |
| TW202334404A (zh) | β冠狀病毒減毒株 | |
| JP4554268B2 (ja) | 分泌型ＩｇＡ抗体誘導剤 | |
| Chary et al. | Protection by recombinant viral proteins against a respiratory challenge with virulent avian metapneumovirus | |
| Chen | Influenza DNA vaccine: an update | |
| ES2557315T3 (es) | Nuevo virus de la gripe | |
| Martins et al. | Characterization of a putative filovirus vaccine: virus-like particles | |
| ES2549366A1 (es) | TRIPLE MUTANTE DEL COMPLEJO MYCOBACTERIUM TUBERCULOSIS erp-, phoP- y DIM- | |
| Rajsri et al. | Efficacy of COVID-19 vaccines against the omicron variant of SARS-CoV-2 | |
| Attaran et al. | Immunogenicity and protective efficacy of recombinant M2e. Hsp70c (Hsp70359–610) fusion protein against influenza virus infection in mice | |
| Bozkurt | Is the impact of childhood vaccines on coronavirus disease 2019, which is moderate in pediatric patients, possible? |